Shanghai Pharmaceuticals Holding Co., Ltd (SHA:601607)

SHA:601607 Revenue

Shanghai Pharmaceuticals Holding had revenue of 75.49B CNY in the quarter ending September 30, 2026, with 2.74% growth. This brings the company's total for the last twelve months to 291.47B, up 3.84% year-over-year. In the year 2025, Shanghai Pharmaceuticals Holding had annual revenue of 283.58B with 3.03% growth. That makes Shanghai Pharmaceuticals Holding the 312th largest company in the world by revenue and 22nd in China.

• Revenue (ttm): 291.47B
• Revenue Growth: +3.84%
• P/S Ratio: 0.19
• Revenue / Employee: 5.88M
• Employees: 48,640
• Market Cap: 53.87B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Distribution 258.83B 88.1%
• Production 24.52B 8.3%
• Retail 8.67B 3.0%
• Other 1.70B 0.6%

By Geography

Chart

• China 277.95B 98.4%
• Foreign 4.60B 1.6%

Fiscal year ended Dec 31, 2025 See the full SHA:601607 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	283.58B	8.33B	3.03%
Dec 31, 2024	275.25B	14.96B	5.75%
Dec 31, 2023	260.30B	28.31B	12.21%
Dec 31, 2022	231.98B	16.16B	7.49%
Dec 31, 2021	215.82B	23.92B	12.46%

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error